Metrics to compare | BVXP | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipBVXPPeersSector | |
|---|---|---|---|---|
P/E Ratio | 11.7x | −3.3x | −0.4x | |
PEG Ratio | −2.40 | 0.01 | 0.00 | |
Price/Book | 7.9x | 3.3x | 2.6x | |
Price / LTM Sales | 6.9x | 5.5x | 3.0x | |
Upside (Analyst Target) | 122.9% | 94.3% | 55.7% | |
Fair Value Upside | Unlock | 0.4% | 8.1% | Unlock |
Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. It offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; Pyrene 1-hydroxypyrene glucuronide (HOP-G) ELISA kit to monitor human exposure to industrial pollutants; and Pyrene (HOP-G) lateral flow kits for monitoring of at-risk individuals without laboratory equipment. The company also provides contract SMAs services; and industrial and environmental biomonitoring platform, which reduces the time between sampling and results. Bioventix PLC was incorporated in 2003 and is based in Farnham, United Kingdom.